A disciplined Danish polymer ‘one-stop-shop’ compounding through Healthcare defensiveness, Cleantech tailwinds, and a transformative prototyping acquisition—while managing leverage and commodity/tariff shocks.
Overview
SP Group A/S is a Denmark-headquartered, Nasdaq Copenhagen-listed specialist manufacturer of advanced plastic and composite components that has evolved from a regional supplier into a global partner for multinational OEMs. Its core proposition is breadth and integration: a “one-stop-shop” polymer solutions platform covering injection molding, vacuum forming, polyurethane reaction injection molding, and coating/finishing, complemented by in-house prototyping and tool manufacturing. Revenue is diversified between customized sub-supplier projects (about 73% of 2025 sales, typically sticky and embedded in customer value chains) and higher-margin own brands (27%), including MedicoPack (medical packaging), Ergomat (ergonomics/safety), and TPI Polyurethanes (farm ventilation). End-market exposure is weighted to high-barrier, mission-critical segments—Healthcare is largest at 40% of revenue, followed by Cleantech at 27% (notably wind) and Foodtech at 13%, with the remainder spanning defense, maritime, and specialized transport. The operating model emphasizes “global partner, local presence,” with 33 manufacturing facilities across Europe, the Americas, and Asia; Europe remains dominant (74% of revenue in 2024–2025). A major 2025 milestone was the acquisition of Idé-Pro BE Holding ApS, adding high-end prototyping, large-scale molding capability, and engineering capacity in Denmark and India, positioning SP Group for a step-change in 2026 growth and capability.